Pre- and Post- COVID-19 Exposure Prophylaxis: Ep4 - Hematologic Malignancies

IMPACT Medicom

IMPACT Medicom द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री IMPACT Medicom या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

2y ago 18:18

MP3•एपिसोड होम

In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination.
In this fourth episode of the series, we discuss:

Response to COVID-19 vaccines in the general population
Response to COVID-19 vaccines in immunocompromised people
The impact of COVID-19 on patients with hematologic malignancies
The potential role of pre- and post- COVID-19 exposure prophylaxis for people with hematologic malignancies

Our Guest:
Our guest on today’s episode is Dr. Carolyn Owen, who is an an Associate Professor in the Division of Hematology & Hematological Malignancies at the University of Calgary.
This podcast episode was sponsored by AstraZeneca Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com

64 एपिसोडस

#Science #Medical Communications #Medical Writing #Agency